Source: Eficode Blog

Eficode Blog Implementing Agile ways of working in a GxP-regulated environment

In the highly regulated biotech sector (where quality and compliance are critical), our client, a Danish biotech company, stands at the forefront of developing innovative human antibody therapies for cancer treatment. Their work requires a relentless commitment to scientific discovery and strict adherence to the rigorous Good Practice (GxP) standards that govern the pharmaceutical and biotech industries.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Ilari Nurmi's photo - CEO of Eficode

CEO

Ilari Nurmi

CEO Approval Rating

98/100

Read more